Survival according to BSA and doxorubicin dose adaptation in patients with DLBCL. PFS (A) and OS (B) according to BSA and doxorubicin dose adaptation in patients with DLBCL (Log-rank, P = .481 and P = .864, respectively). CL, confidence limits.